Search Saint Luke's

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

On the day after Andrew Widman returned home from Saint Luke’s Hospital of Kansas City with his new heart, his wife, Vicki, drove him to the DMV. There he ordered a personalized license plate that read simply “745.” It’s a number that’s particularly close to his heart.

Ramon Grado doesn’t remember driving home and then sprawling on the living room floor on Jan. 13, 2013. Patty, his wife of 33 years, found him there an hour later, awake and complaining about his headache.

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

What began as a middle-of-the-night trip to the bathroom turned into a nightmare—and then a miracle—for 83-year-old Chillicothe resident Shirley Eskew. After getting out of bed, Shirley slipped and fell. “I just hit the concrete hard,” she remembers. Things got blurry after that, but she did manage to call for help and get to the emergency room at Hedrick Medical Center.

Jim Mitchell faced a dilemma — miss rehearsal for a play he was producing during crunch time, or risk having a heart attack. Read his story.

A growing body of evidence correlates shorter running sessions to significant health benefits, especially those regarding longevity and mental health.

A team of cardiologists has used cardiac imaging technology to confirm that cardiovascular disease was a significant issue thousands of years ago.

Dr. Timothy Bateman spoke with Cardiovascular Business about his group's findings and what it is like to work with flurpiridaz.

Percutaneous coronary intervention is associated with significant short-term improvements in high-risk patients with complex coronary artery disease who are ineligible for coronary artery bypass grafting, according to a new analysis.